LAB
STANDARD BIOTOOLS INC.
Key Financials
Net Income
$-74896000
↑ 46.1%
Operating Income
$-110249000
↑ 37.1%
Gross Profit
$42.5M
↓ 49.5%
Revenue
$85.3M
↓ 51.1%
EPS (Diluted)
$-0.20
↑ 61.5%
Total Liabilities
$143.5M
↑ 2.0%
Total Assets
$567.8M
↓ 7.3%
Shareholders' Equity
$424.3M
↓ 10.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 425 | 9/30/2026 | View on SEC |
| 8-K | 9/30/2026 | View on SEC |
| S-4/A | 9/9/2026 | View on SEC |
| 4 | 8/24/2026 | View on SEC |
| 4 | 8/24/2026 | View on SEC |
| 4 | 8/24/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| S-8 | 8/5/2026 | View on SEC |
| S-8 | 8/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LAB |
| Company Name | STANDARD BIOTOOLS INC. |
| CIK | 1162194 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 6502666000 |